11 August 2016
15 October 2015
Professor Maria Makrides, Adelaide University, Australia
A new analysis of data by Professor Makrides’ group at Adelaide University (1) in Australia has shown that in-patient hospital costs could decrease by 92 Australian Dollars (AUD) on average per pregnancy (single) when DHA supplements were consumed during pregnancy. The total potential financial impact of the cost savings to the Australian public hospital system was estimated at being between 15 and 51 million AUD per year (on the basis of 163,519 singleton pregnancies per year). The study calculated that the DHA supplementation provided a 50% chance of avoiding an additional premature birth.
This study used data collected from the “DHA to Optimize Mother and Infant Outcomes” trial (DOMInO) conducted with 2,399 pregnant women supplemented with 800mg DHA per day (in the form of fish oil capsules) recruited from 2005 and 2008 in Australia.
In 2010, the original DOMInO randomized controlled trial conducted by Professor Makrides indicated that supplementation of DHA during pregnancy could reduce the incidence of premature birth, i.e., less than 34 weeks gestation (2).
In a review article (3), Professor Makrides noted that the pregnant women have an increased need of DHA during pregnancy because of the demands of the developing fetus to accrue neural tissue. She also noted that generally in Westernized countries dietary intake was low, and that there was a lack of evidence that DHA could be provided by precursor fatty acids. As such, the investigation of the efficacy of DHA supplementation during pregnancy was justified because of the potential health benefits to both mother and child. At the time of the review, there was conflicting evidence as to the benefit of prenatal DHA supplementation in terms of improved visual acuity and growth in term infants, but this could be explained by the small size of the studies. However, the fact that even large dose interventions of DHA had been used in those trials with no ill effects, provided an incentive for much larger trials to be carried out.
In 2008, her group found that requirement for DHA for optimum visual acuity in premature babies was higher than expected, at 1% of fatty acids, rather than the recommended 0.3% in Australia (4).
In summary, Professor Makrides has shown that prenatal supplementation of pregnant women with DHA reduces the risk of premature birth. This has considerable health benefits for the individuals and cost benefits for the state. She has also shown that supplemental DHA in the formula of premature babies can improve their visual development.
11 August 2016
26 February 2014
In a new statement, the US Preventive Services Task Force concludes that there is not enough evidence from randomized controlled trials for preventive effects of vitamin, mineral and multivitamin supplements in the areas of cancer and cardiovascular disease. Experts criticize that nutrients are not drugs and cannot be expected to show significant effects in clinical studies on multifactorial diseases.
8 September 2015
A new review from China reports that higher blood concentrations of vitamin D may protect against bladder cancer.